James L. Mulshine, MD

Department of Internal Medicine, Associate Provost for Research and Vice President, Rush University, Chicago, IL, USA

Dr. James L. Mulshine, MD, is Acting Dean of the Graduate College as well as the Vice President and Associate Provost of Research at Rush University in Chicago, Illinois. Previously, Dr. Mulshine spent twenty five years at the National Cancer Institute, where he was on the research faculty since 1983 serving at times as the head of the Intervention Section, Chair of the Lung Cancer and Chemoprevention Faculty, as member of the Technology Transfer Review subcommittee for the Director of the National Institutes of Health and Chair of the NCI Institutional Review Board.

Dr. Mulshine is the primary academic officer responsible for managing research activities at Rush University. Internationally recognized as an expert on lung cancer, Dr. Mulshine’s research concentrates on management of early diseases as a key to success in improving outcomes with lung cancer. He has been awarded 12 US patents and has over 300 scientific and medical publications. His work has received both national and international recognition including an appointment as Visiting Professor, Tokyo Medical University from 2003-2006 and the receipt of the Joseph Cullen Award for life-time scientific achievements in lung cancer prevention research from the IASLC in 2007. Dr. Mulshine received his BA from the College of the Holy Cross, and his medical degree from Loyola University Chicago’s Stritch School of Medicine. He received Internal Medicine training at the Cleveland Clinic and Oncology fellowship training at the National Cancer Institute. Dr. Mulshine is on numerous editorial boards and sits on a number of national and international scientific and foundation advisory boards. He is a member of the American Society of Clinical Oncology, the Optical Society of America, American Association of Cancer Research, the American College of Physician and International Association for the Study of Lung Cancer.